Evidence map›Paper›PMID 34670191›Full record

ArticleThe Journal of surgical research2022

Optimization of Ex Vivo Machine Perfusion and Transplantation of Vascularized Composite Allografts.

Laura C Burlage, Alexandre G Lellouch, Corentin B Taveau, Philipp Tratnig-Frankl, Casie A Pendexter, Mark A Randolph, Robert J Porte, Laurent A Lantieri, Shannon N Tessier, Curtis L Cetrulo and 1 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of surgical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Pooled it
  3. Article
  4. Article
  5. 24-hourFrontiers in transplantation · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Laura C BurlageCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts; Department of Surgery, University Medical Center Groningen, Groningen, Netherlands; Vascularized Composite Allotransplantation Laboratory, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, Massachusetts; Division of Plastic and Reconstructive Surgery within the Department of Surgery, Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts; Shriners Hospitals for Children, Boston, Massachusetts. Electronic address: lauraburlage@gmail.com.
Alexandre G LellouchVascularized Composite Allotransplantation Laboratory, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, Massachusetts; Division of Plastic and Reconstructive Surgery within the Department of Surgery, Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts; Shriners Hospitals for Children, Boston, Massachusetts; Division of Plastic and Reconstructive Surgery within the Department of Surgery, European George Pompidou Hospital, University of Paris, Paris, France.
Corentin B TaveauVascularized Composite Allotransplantation Laboratory, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, Massachusetts; Division of Plastic and Reconstructive Surgery within the Department of Surgery, Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts; Shriners Hospitals for Children, Boston, Massachusetts.
Philipp Tratnig-FranklVascularized Composite Allotransplantation Laboratory, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, Massachusetts; Division of Plastic and Reconstructive Surgery within the Department of Surgery, Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts; Shriners Hospitals for Children, Boston, Massachusetts.
Casie A PendexterCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts; Shriners Hospitals for Children, Boston, Massachusetts.
Mark A RandolphVascularized Composite Allotransplantation Laboratory, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, Massachusetts; Division of Plastic and Reconstructive Surgery within the Department of Surgery, Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts; Shriners Hospitals for Children, Boston, Massachusetts.
Robert J PorteDepartment of Surgery, University Medical Center Groningen, Groningen, Netherlands.
Laurent A LantieriDivision of Plastic and Reconstructive Surgery within the Department of Surgery, European George Pompidou Hospital, University of Paris, Paris, France.
Shannon N TessierCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts; Shriners Hospitals for Children, Boston, Massachusetts.
Curtis L CetruloVascularized Composite Allotransplantation Laboratory, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, Massachusetts; Division of Plastic and Reconstructive Surgery within the Department of Surgery, Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts; Shriners Hospitals for Children, Boston, Massachusetts.
Korkut UygunCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts; Shriners Hospitals for Children, Boston, Massachusetts.
Shriners Hospitals for Children - Erie · USUniversity Medical Center Groningen · NLHôpital Européen Georges-Pompidou · FR

Funding

Genetic-engineered control of the immunogeneic state of vascular composite allografts during preservationR01EB028782 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI Biju Parekkadan, Korkut Uygun · 2021 to 2026
$3.1M
High subzero heart preservation: from zebrafish to mammalsR01HL157803 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Shannon Noella Tessier · 2021 to 2026
$2.8M
Isochoric Pressure Based Preservation of Cells, Tissues and OrgansR44AI145782 · NIAID · SYLVATICA BIOTECH, INC. · PI BRANDACHER, GERALD, RUBINSKY, BORIS · 2019 to 2021
$2.2M
High Subzero Equilibrium VCA CryopreservationR44AI124835 · NIAID · SYLVATICA BIOTECH, INC. · PI TAYLOR, MICHAEL JOHN, UYGUN, KORKUT · 2018 to 2020
$1.9M
Whole heart suspended animation: leveraging the zebrafish to solve the organ shortageR00HL143149 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI TESSIER, SHANNON NOELLA · 2021 to 2023
$747k
NHLBI NIH HHS R00 HL143149NHLBI NIH HHS R01 HL157803NIAID NIH HHS R44 AI124835NIAID NIH HHS R44 AI145782NIBIB NIH HHS R01 EB028782
6 · The paper itself

Abstract

backgroundMachine perfusion is gaining interest as an efficient method of tissue preservation of Vascularized Composite Allografts (VCA). The aim of this study was to develop a protocol for ex vivo subnormothermic oxygenated machine perfusion (SNMP) on rodent hindlimbs and to validate our protocol in a heterotopic hindlimb transplant model.

methodsIn this optimization study we compared three different solutions during 6 h of SNMP (n = 4 per group). Ten control limbs were stored in a preservation solution on Static Cold Storage [SCS]). During SNMP we monitored arterial flowrate, lactate levels, and edema. After SNMP, muscle biopsies were taken for histology examination, and energy charge analysis. We validated the best perfusion protocol in a heterotopic limb transplantation model with 30-d follow up (n = 13). As controls, we transplanted untreated limbs (n = 5) and hindlimbs preserved with either 6 or 24 h of SCS (n = 4 and n = 5).

resultsDuring SNMP, arterial outflow increased, and lactate clearance decreased in all groups. Total edema was significantly lower in the HBOC-201 group compared to the BSA group (P = 0.005), 4.9 (4.3-6.1) versus 48.8 (39.1-53.2) percentage, but not to the BSA + PEG group (P = 0.19). Energy charge levels of SCS controls decreased 4-fold compared to limbs perfused with acellular oxygen carrier HBOC-201, 0.10 (0.07-0.17) versus 0.46 (0.42-0.49) respectively (P = 0.002).

conclusionsSix hours ex vivo SNMP of rodent hindlimbs using an acellular oxygen carrier HBOC-201 results in superior tissue preservation compared to conventional SCS.

Indexed as

Composite Tissue AllograftsOrgan PreservationAllograftsAnimalsExtremitiesOxygenPerfusionOxygenEnergy chargeFace transplantationFree flapLimb transplantationOxygenated machine perfusionOxygen carrierPlastic surgeryPreservationVascularized composite allotransplantation

Identifiers

PMID34670191
PMCPMC8712379
OpenAlexW3205737639

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.